Treatment of Hepatitis B Virus-Associated Membranous Nephropathy: Lamivudine Era versus Post-Lamivudine Era
Ju-Young Moon, Sang Ho Lee
Korean J Intern Med. 2012;27(4):394-396. Published online 2012 Nov 27 DOI: https://doi.org/10.3904/kjim.2012.27.4.394
Citations to this article as recorded by 
Primary Membranous Glomerulonephritis: The Role of Serum and Urine Biomarkers in Patient Management
Maifata, Hod, Zakaria, Abd Ghani
Biomedicines.2019; 7(4): 86. CrossRef
Autoimmune Kidney Diseases Associated with Chronic Viral Infections
Joshua D. Long, Stephanie M. Rutledge, Meghan E. Sise
Rheumatic Disease Clinics of North America.2018; 44(4): 675. CrossRef
WITHDRAWN: The combination of tacrolimus and entecavir improves the remission of HBV-associated glomerulonephritis without enhancing viral replication
Lifen Wang, Zhiming Ye, Huaban Liang, Bin Zhang, Lixia Xu, Zhonglin Feng, Shuangxin Liu, Wei Shi
Clinica Chimica Acta.2016;[Epub] CrossRef
A higher frequency of IL‐10‐producing B cells in Hepatitis B virus‐associated membranous nephropathy
Yong Liu, Haifeng Wang, Xintong Hu, Zhihui Qu, Huimao Zhang, Rebecca Crew, Desalegn Admassu Ayana, Man Li, Jinpeng Qiu, Yanfang Jiang
Clinical and Experimental Pharmacology and Physiology.2016; 43(4): 417. CrossRef
Frequency of CD4+CXCR5+ TFH cells in patients with hepatitis b virus-associated membranous nephropathy
Yong Liu, Pingwei Zhao, Zhihui Qu, Desalegn Admassu Ayana, Yanfang Jiang
International Immunopharmacology.2014; 22(1): 98. CrossRef